secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001493152-23-023932
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics exchanges warrants for common stock and Series A Preferred at $0.199/share
--------------------------------------------------------------------------------

- Entered Warrant Exchange Agreements with holders of warrants issued Oct 2020–Feb 2023.
- Exchange ratio: 1 share of common stock for 2 warrants; certain holders receive Series A Preferred to cap beneficial ownership.
- Series A Preferred converts to common at $0.199 per share, has same dividend/liquidation rights as common, no voting rights.
- Preferred Stock issued to accredited investors in private placement exempt from registration under Section 4(a)(2).
- Certificate of Designation for Series A Preferred filed with Delaware; no redemption rights, anti-dilution adjustments apply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223023932/0001493152-23-023932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223023932/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer